ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Psychiatry

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

14,909Medicare Part D Prescriptions Filled, Including Refills

Rank: 3 out of 334

$2.07M Total Retail Price of All Prescriptions

Rank: 5 out of 334

649 Patients Receiving at Least One Drug in Part D
21%Patients 65 Years and Older
97% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Missouri
Lower avg

Schedule Two
Controlled Substances

2% of this provider’s 649 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

N/A

Risky Drugs to Seniors

0% of this provider’s 1,934 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

29% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$139 was the average price of a prescription from this provider, compared to $130 among peers.

Prescriptions per Patient

23 is the average number of prescriptions (including refills) per patient, compared to an average of 16.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Missouri
ESCITALOPRAM OXALATE 617 151 1 17
RISPERIDONE 615 106 2 2
BENZTROPINE MESYLATE 600 0 R 3 9
MIRTAZAPINE 589 140 4 13
ZOLPIDEM TARTRATE 476 56 5 8
INVEGA 475 38 10 6 34
LAMOTRIGINE 473 36 7 6
TRAZODONE HCL 466 31 8 1
BUPROPION XL 458 0 9 16
NAMENDA 446 281 10 33
ABILIFY 430 92 11 5
OLANZAPINE 393 68 12 15
SERTRALINE HCL 385 72 13 10
QUETIAPINE FUMARATE 380 37 14 7
TOPIRAMATE 358 14 15 28
DIVALPROEX SODIUM ER 356 69 16 14
CYMBALTA 328 0 17 3
CITALOPRAM HBR 310 55 18 4
HALOPERIDOL 308 31 19 24
CLOZAPINE 308 18 19 19
FLUOXETINE HCL 304 33 21 11
BUSPIRONE HCL 268 26 22 20
PAROXETINE HCL 256 42 23 23
LITHIUM CARBONATE 232 0 24 18
DONEPEZIL HCL 219 119 25 38
SEROQUEL XR 185 0 26 25
VENLAFAXINE HCL ER 176 0 27 12
LATUDA 162 11 28 41
ZYPREXA 144 0 29 48
SEROQUEL 141 19 30 27
TRIHEXYPHENIDYL HCL 115 0 R 31 42
CARBAMAZEPINE XR 109 0 32 89
SIMVASTATIN 107 0 33 67
HYDROXYZINE PAMOATE 107 0 R 33 22
DIVALPROEX SODIUM 103 23 35 26
LEXAPRO 96 22 36 45
EXELON 95 72 37 61
NALTREXONE HCL 95 0 37 94
CARBAMAZEPINE 92 12 39 39
HALOPERIDOL DECANOATE 92 0 39 47
RISPERDAL CONSTA 91 0 41 36
FAMOTIDINE 89 0 42 92
GABAPENTIN 85 13 43 29
INVEGA SUSTENNA 84 0 44 35
LEVOTHYROXINE SODIUM 83 14 45 54
LUNESTA 80 0 46 40
TRAMADOL HCL 79 0 47 94
RANITIDINE HCL 78 0 48 76
FLUVOXAMINE MALEATE 77 0 49 63
AMPHETAMINE SALT COMBO 72 0 S2 50 37
PRAZOSIN HCL 64 0 51 56
AMLODIPINE BESYLATE 63 0 52 98
CARBAMAZEPINE ER 63 0 52 130
ZIPRASIDONE HCL 60 0 54 30
ATORVASTATIN CALCIUM 56 0 55 142
METFORMIN HCL 56 13 55 72
IBUPROFEN 55 0 57 79
LISINOPRIL 55 0 57 70
OXCARBAZEPINE 53 23 59 32
TEGRETOL XR 51 0 60 145
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.